These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3084078)

  • 1. Selective modulation by alpha-difluoromethylornithine of T-lymphocyte and antibody-mediated cytotoxic responses to mouse tumor allografts.
    Ehrke MJ; Porter CW; Eppolito C; Mihich E
    Cancer Res; 1986 Jun; 46(6):2798-803. PubMed ID: 3084078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of polyamine depletion in vivo by DL-alpha-difluoromethylornithine on functionally distinct populations of tumoricidal effector cells in normal and tumor-bearing mice.
    Bowlin TL; McKown BJ; Davis GF; Sunkara PS
    Cancer Res; 1986 Nov; 46(11):5494-8. PubMed ID: 3093066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
    Heston WD; Fleischmann J; Tackett RE; Ratliff TL
    Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of three irreversible inhibitors of ornithine decarboxylase on macrophage-mediated tumoricidal activity and antitumor activity in B16F1 tumor-bearing mice.
    Bowlin TL; Hoeper BJ; Rosenberger AL; Davis GF; Sunkara PS
    Cancer Res; 1990 Aug; 50(15):4510-4. PubMed ID: 2114941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, augments cyclosporin A inhibition of cytolytic T lymphocyte induction.
    Bowlin TL; Rosenberger AL; McKown BJ
    Clin Exp Immunol; 1989 Jul; 77(1):151-6. PubMed ID: 2504519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo.
    Sunkara PS; Chang CC; Prakash NJ; Lachmann PJ
    Cancer Res; 1985 Sep; 45(9):4067-70. PubMed ID: 3928149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two bisdioxopiperazines on mouse B-and T-cell function.
    Dennert G; Hatlen LE; Tucker DF
    J Natl Cancer Inst; 1975 Mar; 54(3):621-9. PubMed ID: 804564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of host antitumor defense mechanisms in mice by progressively growing tumor.
    Maccubbin DL; Mace KF; Ehrke MJ; Mihich E
    Cancer Res; 1989 Aug; 49(15):4216-24. PubMed ID: 2525950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice.
    Sunkara PS; Rosenberger AL
    Cancer Res; 1987 Feb; 47(4):933-5. PubMed ID: 3100031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment with DL-alpha-difluoromethylornithine in established human small cell variant lung carcinoma implants in athymic mice.
    Luk GD; Abeloff MD; Griffin CA; Baylin SB
    Cancer Res; 1983 Sep; 43(9):4239-43. PubMed ID: 6409400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy involving alpha-difluoromethylornithine and 1-beta-D-arabinofuranosylcytosine in murine L1210 leukemia.
    Prakash NJ; Sunkara PS
    Cancer Res; 1983 Jul; 43(7):3192-6. PubMed ID: 6406054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment.
    Tomazic V; Ehrke MJ; Mihich E
    Cancer Res; 1981 Sep; 41(9 Pt 1):3370-6. PubMed ID: 7260903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of uptake and antiproliferative effect of methylglyoxal bis(guanylhydrazone) by treatment with alpha-difluoromethylornithine in rodent cell lines with different sensitivities to methylglyoxal bis(guanylhydrazone).
    Alhonen-Hongisto L; Levin VA; Marton LJ
    Cancer Res; 1985 Feb; 45(2):509-14. PubMed ID: 3917847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective modulation of antibody response and natural killer cell activity by purine nucleoside analogues.
    Priebe T; Kandil O; Nakic M; Pan BF; Nelson JA
    Cancer Res; 1988 Sep; 48(17):4799-803. PubMed ID: 3261625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alpha-difluoromethylornithine on the growth of experimental Wilms' tumor and renal adenocarcinoma.
    Kingsnorth AN; McCann PP; Diekema KA; Ross JS; Malt RA
    Cancer Res; 1983 Sep; 43(9):4031-4. PubMed ID: 6307502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
    Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
    Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
    Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
    Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.